Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.
Inuvo, Inc. (NYSEMKT: INUV) shares tumbled 16.80 percent to close at $1.04 a share Tuesday. The stock traded between $0.91 and $1.05 on volume 1.24 million shares traded. The company reported net revenues were $11.4 million in the fourth quarter of 2013, down from $16.2 million a year ago. Shares of Inuvo are down approximately 20.0 percent year-to-date.
Get more information on Inuvo and free access to the in-depth equity report at:
Myriad Genetics, Inc. (NASDAQ: MYGN) shares fell 8.34 percent to close at $34.60 a share Tuesday. The stock traded between $32.76 and $35.74 on volume of 6.22 million shares traded. A Utah court has denied the company’s motion to block Ambry Genetics from selling its BRCA 1 and BRCA 2 gene tests. Shares of Myriad Genetics are up approximately 65.0 percent year-to-date.
Get more information on Myriad Genetics and free access to the in-depth equity report at:
Nuverra Environmental Solutions Inc. (NYSE: NES) shares dropped 15.23 percent to close at $15.25 a share Tuesday. The stock traded between $15.06 and $17.88 on volume 1.55 million shares traded. The company has agreed to sell its Industrial Solutions segment, Thermo Fluids Inc., to VeroLube, Inc. for $175.0 million. Shares of Nuverra Environmental are down approximately 9.0 percent year-to-date.
Get more information on Nuverra Environmental free access to the in-depth equity report at:
Outerwall Inc. (NASDAQ: OUTR) shares declined 5.69 percent to close at $64.51 a share Tuesday. The stock traded between $64.43 and $66.83 on volume of 1.92 million shares traded. Jana Partners recently disclosed that it has decreased its stake in the company to 8.4 percent from 13.5 percent. Shares of Outerwall are down approximately 4.0 percent year-to-date.
Get more information on Outerwall and free access to the in-depth equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Five Star Equities